Capital Group Private Client Services, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Capital Group Private Client Services, Inc.
- $5.15 Billion
- Q3 2025
A detailed history of Capital Group Private Client Services, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Capital Group Private Client Services, Inc. holds 2,907 shares of REGN stock, worth $2.02 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,907
Previous 22,872
87.29%
Holding current value
$2.02 Million
Previous $12 Million
86.39%
% of portfolio
0.03%
Previous 0.11%
Shares
15 transactions
Others Institutions Holding REGN
# of Institutions
1,466Shares Held
86.5MCall Options Held
2.38MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...